Colombia: With gene editing technology, they seek to reduce embryonic and fetal mortality in cows

Published 2021년 9월 29일

Tridge summary

The Texas A&M AgriLife Research Center is using CRISPR-Cas9 gene deletion technology to investigate the role of glycoproteins in embryonic mortality in cattle, with the goal of reducing abortions and minimizing economic losses for the meat industry. A $500,000 grant from the US Department of Agriculture's National Institute of Food and Agriculture supports this research, focusing on the physiological and molecular mechanisms of embryonic survival and mortality in cattle. The study aims to develop strategies to prevent embryonic loss and improve management techniques, with a particular focus on identifying the contribution of the bull or the cow to this issue.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The Texas A&M AgriLife Research Center is investigating CRISPR-Cas9 gene deletion technology to determine the role of glycoproteins in embryonic mortality in cattle. With this, strategies could be implemented to reduce abortions in cows. Ky Pohler, president of the Area of Excellence in Pregnancy Programming and Development at the Texas A&M College of Agriculture and Life Sciences, said the meat industry loses billions a year due to embryonic losses. “We are conducting a series of studies to evaluate what is really important for the development of pregnancy. We want to determine how much of the loss comes from the animal's physiology versus how much is genetic, ”he told Tri-State Livestock News. When a cow loses a calf or suffers embryonic mortality, the cow may not become pregnant again in that breeding season. (Read: This is how genetic editing in livestock farming would help production and the environment) To understand this phenomenon, Pohler and his team advance a project ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.